SARAH KACHMAN: Open Payments
NPI 1821467689 · TERRE HAUTE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,222 in 51 payments from 15 companies in 2025. Trend: 2023 $1,219 · 2024 $1,375 · 2025 $1,222
Food & beverage: $1,222
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $261 |
| Novartis Pharmaceuticals Corporation | 8 | $246 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $119 |
| Boston Scientific Corporation | 4 | $100 |
| PFIZER INC. | 5 | $98 |
| Merck Sharp & Dohme LLC | 4 | $79 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $75 |
| Actelion Pharmaceuticals US, Inc. | 3 | $68 |
| E.R. Squibb & Sons, L.L.C. | 2 | $37 |
| SCPHARMACEUTICALS INC. | 1 | $33 |
Products named: LEQVIO, Wegovy, JARDIANCE, Ozempic, VERQUVO, WATCHMAN FLX, ELIQUIS, Kerendia.
Industry payments across IN — which companies pay providers there.
